Catalent
AcquiredLeading Global CDMO Pharma Solutions
- Headquarters
- New Jersey
- Employees
- 10001+
- Business Model
- B2B
- Website
- catalent.com
- Acquisition Date
- Jan 2024
About
Global contract development and manufacturing organization (CDMO) providing drug delivery technologies, drug development, biologics, gene therapy, and consumer health products.
Summary
Catalent is a Biotech company based in United States. Investors include Novo Holdings A/S.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2024
Sign up to see all 2 rounds
IPO through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/catalent"><img src="https://indexed.vc/api/badge/company/catalent" alt="Catalent on Indexed.vc" width="260" height="76" /></a>